Government of Canada invests in regenerative medicine, genomics research to support Canadians’ health – Canada NewsWire

Funding will help fight cancer and blood disorders and address environmental and agricultural challenges

OTTAWA, ON, Oct. 26, 2020 /CNW/ - As the Government of Canada focuses on responding to the challenges of COVID-19, the importance of investing in science and research is clearer than ever. These investments allow researchers to produce the breakthroughs that improve our daily lives, from delivering cutting-edge therapeutics for treating diseases and chronic conditions to developing new technologies that will help Canadian farmers better protect their crops and livestock.

Today, William Amos, Parliamentary Secretary to the Minister of Innovation, Science and Industry (Science), on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Industry, announced an investment of more than $20 million to support advances in stem cell and regenerative medicine and support genomics research.

Today's investments include:

Quotes

"The Government of Canada is proud to support Canada's world-leading stem cell and genomics research community. Today's investment has the potential to save lives and come up with new ways of solving environmental and agricultural challenges. This is Canadian science and innovation in action." William Amos, Parliamentary Secretary to the Minister of Innovation, Science and Industry (Science)

"The health and safety of Canadians remains the government's top priority, and the COVID-19 pandemic has illustrated the continued importance of investing in science and research. I would like to extend my congratulations and gratitude to today's recipients, who continue to work so tirelessly to improve the lives of Canadians. The Government of Canada is committed to supporting science and research, which has far-reaching impacts on Canadians' health and day-to-day lives." The Honourable Navdeep Bains, Minister of Innovation, Science, and Industry

"The projects the Stem Cell Network is funding underscore the depth, breadth and innovation of this highly diverse and collaborative community. Thanks to the continued, long-term funding of the Government of Canada, we will continue to deliver leading-edge and viable stem cellbased therapeutics to treat serious illnesses and chronic diseases, for the benefit of all Canadians." Dr. Michael Rudnicki, O.C., FRS, FRSC, Scientific Director & CEO, Stem Cell Network

"Research will be a key driver of Canada's economic recovery and long-term prosperity. Investments in leading genomics research and technology will support the development of sustainable agriculture, more resilient food systems, healthier communities and a greener resource sector. Genome Canada, in partnership with the Government of Canada, is proud to support collaboration between research institutions and industry that will have transformative impacts on the lives of Canadians."Dr. Rob Annan, President and CEO, Genome Canada

Quick facts

Associated links

For Canadian Science news, follow @CDNScienceon social media: Twitter, Instagram, FacebookFollow Innovation, Science and Economic Development Canada on Twitter: @ISED_CAFollow Stem Cell Network on Twitter: @StemCellNetworkFollow Genome Canada on Twitter: @GenomeCanada

SOURCE Innovation, Science and Economic Development Canada

For further information: John Power, Press Secretary, Office of the Minister of Innovation, Science and Industry, 343-550-1456, [emailprotected]; Media Relations, Innovation, Science and Economic Development Canada, 343-291-1777, [emailprotected]; Janice Nicholson, Director of Communications, Stem Cell Network, 613-402-3974, [emailprotected]; Nicola Katz, Director, Communications, Genome Canada, 613-297-0267, [emailprotected]

http://www.ic.gc.ca/eic/site/icgc.nsf/eng/home

Go here to see the original:

Government of Canada invests in regenerative medicine, genomics research to support Canadians' health - Canada NewsWire